148 related articles for article (PubMed ID: 6099065)
1. A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate.
Andrews PA; Wung WE; Howell SB
Anal Biochem; 1984 Nov; 143(1):46-56. PubMed ID: 6099065
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the pharmacokinetics of ultrafilterable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy.
Goel R; Andrews PA; Pfeifle CE; Abramson IS; Kirmani S; Howell SB
Eur J Cancer; 1990 Jan; 26(1):21-7. PubMed ID: 2156545
[TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatographic determination of platinum (II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrometric method.
Drummer OH; Proudfoot A; Howes L; Louis WJ
Clin Chim Acta; 1984 Jan; 136(1):65-74. PubMed ID: 6319051
[TBL] [Abstract][Full Text] [Related]
4. Quantitative liquid chromatographic determination of intact cisplatin in blood with microwave-assisted post-column derivatization and UV detection.
Pierre PV; Wallin I; Eksborg S; Ehrsson H
J Pharm Biomed Anal; 2011 Aug; 56(1):126-30. PubMed ID: 21621941
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic determination of cis-dichlorodiammineplatinum(II) in plasma ultrafiltrate.
Augey V; Cociglio M; Galtier M; Yearoo R; Pinsani V; Bressolle F
J Pharm Biomed Anal; 1995 Aug; 13(9):1173-8. PubMed ID: 8573645
[TBL] [Abstract][Full Text] [Related]
6. Urine analysis of platinum species derived from cis-dichlorodiammineplatinum(II) by high-performance liquid chromatography following derivatization with sodium diethyldithiocarbamate.
Bannister SJ; Sternson LA; Repta AJ
J Chromatogr; 1979 May; 173(2):333-42. PubMed ID: 232706
[TBL] [Abstract][Full Text] [Related]
7. High-dose cisplatin with diethyldithiocarbamate (DDTC) rescue therapy: preliminary pharmacologic observations.
DeGregorio MW; Gandara DR; Holleran WM; Perez EA; King CC; Wold HG; Montine TJ; Borch RF
Cancer Chemother Pharmacol; 1989; 23(5):276-8. PubMed ID: 2539912
[TBL] [Abstract][Full Text] [Related]
8. Low-level (PPB) determination of cisplatin in cleaning validation (rinse water) samples. II. A high-performance liquid chromatographic method.
Raghavan R; Burchett M; Loffredo D; Mulligan JA
Drug Dev Ind Pharm; 2000 Apr; 26(4):429-40. PubMed ID: 10769785
[TBL] [Abstract][Full Text] [Related]
9. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.
Bodenner DL; Dedon PC; Keng PC; Borch RF
Cancer Res; 1986 Jun; 46(6):2745-50. PubMed ID: 2870800
[TBL] [Abstract][Full Text] [Related]
10. Chemical reactivity of cisplatin bound to human plasma proteins.
Hegedüs L; van der Vijgh WJ; Klein I; Kerpel-Fronius S; Pinedo HM
Cancer Chemother Pharmacol; 1987; 20(3):211-2. PubMed ID: 2824080
[TBL] [Abstract][Full Text] [Related]
11. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic determination of cisplatin as platinum(II) in a pharmaceutical preparation and blood samples of cancer patients.
Khuhawar MY; Lanjwani SN; Memon SA
J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):175-9. PubMed ID: 9200532
[TBL] [Abstract][Full Text] [Related]
13. Sensitive high-performance liquid chromatographic assay for platinum in plasma ultrafiltrate.
Reece PA; McCall JT; Powis G; Richardson RL
J Chromatogr; 1984 Mar; 306():417-23. PubMed ID: 6538883
[No Abstract] [Full Text] [Related]
14. Determination of platinum in serum and ultrafiltrate by flameless atomic absorption spectrophotometry.
Hull DA; Muhammad N; Lanese JG; Reich SD; Finkelstein TT; Fandrich S
J Pharm Sci; 1981 May; 70(5):500-2. PubMed ID: 7241351
[TBL] [Abstract][Full Text] [Related]
15. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.
Montine TJ; Borch RF
Cancer Res; 1988 Nov; 48(21):6017-24. PubMed ID: 2458831
[TBL] [Abstract][Full Text] [Related]
16. Atomic absorption spectrophotometry of free circulating platinum species in plasma derived from cis-dichlorodiammineplatinum(II).
Bannister SJ; Chang Y; Sternson LA; Repta AJ
Clin Chem; 1978 Jun; 24(6):877-80. PubMed ID: 657475
[TBL] [Abstract][Full Text] [Related]
17. Determination of platinum traces contamination by graphite furnace atomic absorption spectrometry after preconcentration by cloud point extraction.
Chappuy M; Caudron E; Bellanger A; Pradeau D
J Hazard Mater; 2010 Apr; 176(1-3):207-12. PubMed ID: 19962825
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of diethyldithiocarbamate and N-benzyl-D-glucamine dithiocarbamate on cis-diamminedichloroplatinum-induced toxicity in kidney and gastrointestinal tract in rats.
Hidaka S; Funakoshi T; Shimada H; Tsuruoka M; Kojima S
J Appl Toxicol; 1995; 15(4):267-73. PubMed ID: 7594195
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a LC-MS/MS assay for quantification of cisplatin in rat plasma and urine.
Shaik AN; Altomare DA; Lesko LJ; Trame MN
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1046():243-249. PubMed ID: 28162967
[TBL] [Abstract][Full Text] [Related]
20. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
Martinčič A; Cemazar M; Sersa G; Kovač V; Milačič R; Ščančar J
Talanta; 2013 Nov; 116():141-8. PubMed ID: 24148385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
